Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.

Patrick G Morris,Selene Rota,Karen Cadoo,Stephen Zamora,Sujata Patil,Gabriella D'Andrea,Theresa Gilewski,Jacqueline Bromberg,Chau Dang,Maura Dickler,Shanu Modi,Andrew D Seidman,Nancy Sklarin,Larry Norton,Clifford A Hudis,Monica N Fornier

Clinical Breast Cancer（2018）

引用 38|浏览81

暂无评分

摘要

This phase II study of dasatinib and paclitaxel was stopped early because of slow accrual but showed some clinical activity. Further study is not planned.

查看译文

关键词

Advanced breast cancer,Dasatinib,Metastatic breast cancer,Paclitaxel,SRC

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要